Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by Sandman852on Mar 10, 2020 12:23pm
118 Views
Post# 30788876

RE:RE:CZO: big market for Juvente in South America.

RE:RE:CZO: big market for Juvente in South America.
Ciao wrote:
Royal10 wrote:
Yield Growth Co (BOSS.V) confirms that Gilles Gagnon is right when he sees great opportunies for Juvente's cannabinoids products in a HUGE MARKET in South America: "According to Goldstein Research, the Latin America cosmetics market reached a value of $31.98-billion (U.S.) in 2017 and is anticipated to grow at a CAGR (compound annual growth rate) of 4.49 per cent during the forecast period 2017 to 2025." Extract from today's PR by BOSS: YIELD GROWTH ANNOUNCES FIRST PRODUCT SHIPMENT TO COLOMBIA UNDER THE 8 COUNTRY LATIN AMERICAN DISTRIBUTION DEAL


We must stretching it to make news for ourselves.


       As a former shareholder i don't take any pleasure in saying that i dumped this stock BECAUSE of the total lack of professionalism and arrogance of the CEO.  It appears that those characteristics continue to plague this company and seriously impact potential sales etc.  IF there ever was proof that management makes the company- or kills it.. this is it.  I feel for those who have stuck with this stock in hopes of hitting the potential, but more than ever i now believe Gagnon does nothing but harm to any chance of building the product / brand etc.  THEY NEED HIM OUT ! imo 
Bullboard Posts